Conference Programme
Maximising Returns from Life Science Innovation
10 December 2026
Maximising Returns from Life Science Innovation
Plenary Programme
Taking place again in the Guy Whittle Auditorium, the 2026 Keynote Programme at Genesis will explore the exciting potential offered by innovation in life sciences to address global unmet medical needs, investment returns and new treatment development challenges. The sessions will discuss how the barriers to progress can be defeated through creative thinking in R&D, collaboration, investment and patient access to translate the golden triangle of ‘technology-people-money’ into value creation for all stakeholders.
Provisional Agenda (Subject to Change)
Registration
Welcome from One Nucleus
Tony Jones, CEO, One Nucleus
SESSION 1
Plenary Address: Winners & Losers 2026
Mike Ward, Global Head of Life Sciences Thought Leadership, Clarivate
Plenary Panel: How can you scale a UK biotech without selling out to a richer international counterpart?
Refreshments, Exhibition & Networking
SESSION 2
Keynote Panel 1: What is the Next Scientific Frontier in Bio-innovation?
Keynote Panel 2: How Can the UK and EU Increase Their Competitiveness in the Global Life Science Industry?
Lunch, Exhibition & Networking
SESSION 3
Keynote Panel 3: Is the UK a Rare Gem?
Keynote Panel 4 – How Relevant is the Current Biopharma Business Model in the Era of Bioconvergence and Techbio?
Refreshments, Exhibition & Networking
SESSION 4
Fireside Chat – A Patient’s Perspective
Keynote Panel 5 – Will the Innovators, Investors and Regulators of the Future Be Human Or Machine?
Closing Remarks
Tony Jones
Drinks Reception
Close
Programme is subject to change